Vor Biopharma Inc is a clinical stage cell therapy company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
VOR is expected to report earnings to fall 42.80% to -25 cents per share on May 08
Q1'25
Est.
$-0.25
Q4'24
Missed
by $0.10
Q3'24
Est.
$-0.40
Q2'24
Beat
by $0.01
Q1'24
Missed
by $0.06
The last earnings report on March 20 showed earnings per share of -43 cents, missing the estimate of -33 cents. With 179.29K shares outstanding, the current market capitalization sits at 87.40M.